€27.50
0.00% day before yesterday
Xetra, Sep 12, 05:35 pm CET
ISIN
DE000STRA555
Symbol
SBS
Index

STRATEC Stock price

€27.50
+0.95 3.58% 1M
+0.55 2.04% 6M
-2.30 7.72% YTD
-13.10 32.27% 1Y
-58.10 67.87% 3Y
-76.90 73.66% 5Y
-21.10 43.42% 10Y
-12.50 31.25% 20Y
Xetra, Closing price Fri, Sep 12 2025
+0.00 0.00%
ISIN
DE000STRA555
Symbol
SBS
Index

Key metrics

Basic
Market capitalization
€334.3m
Enterprise Value
€442.3m
Net debt
€108.0m
Cash
€20.7m
Shares outstanding
12.2m
Valuation (TTM | estimate)
P/E
22.7 | 17.2
P/S
1.3 | 1.2
EV/Sales
1.7 | 1.6
EV/FCF
62.4
P/B
1.4
Dividends
DPS
€0.60
Yield 1Y | 5Y
2.2% | 1.0%
Growth 1Y | 5Y
9.1% | -6.5%
Payout 1Y | 3Y
45.5% | 42.6%
Increased
1 Year
Financials (TTM | estimate)
Revenue
€257.1m | €271.6m
EBITDA
€45.9m | €52.2m
EBIT
€26.8m | €28.4m
Net Income
€14.7m | €19.5m
Free Cash Flow
€7.1m
Growth (TTM | estimate)
Revenue
0.5% | 5.4%
EBITDA
3.6% | 9.5%
EBIT
5.6% | 0.9%
Net Income
0.8% | 21.4%
Free Cash Flow
-54.8%
Margin (TTM | estimate)
Gross
30.3%
EBITDA
17.9% | 19.2%
EBIT
10.4%
Net
5.7% | 7.2%
Free Cash Flow
2.8%
Financial Health
Equity Ratio
54.5%
Return on Equity
6.6%
ROCE
7.5%
ROIC
5.3%
Debt/Equity
0.5
More
EPS
€1.2
FCF per Share
€0.6
Short interest
-
Employees
1k
Rev per Employee
€180.0k
Show more

Is STRATEC a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,008 stocks worldwide.

STRATEC Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a STRATEC forecast:

9x Buy
69%
4x Hold
31%

Analyst Opinions

13 Analysts have issued a STRATEC forecast:

Buy
69%
Hold
31%

Financial data from STRATEC

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
257 257
0% 0%
100%
- Direct Costs 179 179
4% 4%
70%
78 78
12% 12%
30%
- Selling and Administrative Expenses 38 38
13% 13%
15%
- Research and Development Expense 11 11
17% 17%
4%
46 46
4% 4%
18%
- Depreciation and Amortization 19 19
1% 1%
7%
EBIT (Operating Income) EBIT 27 27
6% 6%
10%
Net Profit 15 15
1% 1%
6%

In millions EUR.

Don't miss a Thing! We will send you all news about STRATEC directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

STRATEC Stock News

AD HOC NEWS
24 days ago
Hauck Aufhäuser Investment Banking hat das Kursziel für Stratec DE000STRA555 nach Halbjahreszahlen von 31 auf 30 Euro gesenkt und die Einstufung auf "Hold" belassen.
AD HOC NEWS
24 days ago
Die Privatbank Berenberg hat das Kursziel für Stratec DE000STRA555 m Zuge eines Analystenwechsels von 50 auf 51 Euro angehoben und die Einstufung auf "Buy" belassen.
AD HOC NEWS
27 days ago
STRATEC SE / DE000STRA555
More STRATEC News

Company Profile

STRATEC SE engages in the design and manufacture of automated analyzer systems in the fields of clinical diagnostic and biotechnology. It operates through the following segments: Instrumentation, Diatron, Smart Consumables, and Other Activities. The Instrumentation segment consults, designs, develops and produces fully automated solutions for its partners in the fields of diagnostics including blood banking. The Diatron segment comprises the business with systems, system components, consumables and tests in the low throughput hematology and clinical chemistry segment. The Smart Consumables segment includes the business with developing and manufacturing smart consumables in the fields of diagnostics, life sciences, and medical technology. The Other Activities segment covers the development of work flow software for networking several analyzer systems and the development and sale of scientific materials and technologies. The company was founded by Hermann Leistner in 1979 and is headquartered in Birkenfeld, Germany.

Head office Germany
CEO Marcus Wolfinger
Employees 1,462
Founded 1979
Website www.stratec.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today